Miller VA - Search Results

1

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.

Miller VA, Benedetti FM, Rigas JR, Verret AL, Pfister DG, Straus D, Kris MG, Crisp M, Heyman R, Loewen GR, Truglia JA, Warrell RP Jr. Miller VA, et al. J Clin Oncol. 1997 Feb;15(2):790-5. doi: 10.1200/JCO.1997.15.2.790. J Clin Oncol. 1997. PMID: 9053506 Clinical Trial.

2

Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer.

Miller VA, Johnson DH, Krug LM, Pizzo B, Tyson L, Perez W, Krozely P, Sandler A, Carbone D, Heelan RT, Kris MG, Smith R, Ochs J. Miller VA, et al. J Clin Oncol. 2003 Jun 1;21(11):2094-100. doi: 10.1200/JCO.2003.12.008. J Clin Oncol. 2003. PMID: 12775734 Clinical Trial.

3

Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.

Rizvi NA, Riely GJ, Azzoli CG, Miller VA, Ng KK, Fiore J, Chia G, Brower M, Heelan R, Hawkins MJ, Kris MG. Rizvi NA, et al. Among authors: miller va. J Clin Oncol. 2008 Feb 1;26(4):639-43. doi: 10.1200/JCO.2007.10.8605. J Clin Oncol. 2008. PMID: 18235124 Clinical Trial.

4

Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.

Miller VA, Rigas JR, Pisters KM, Grant SC, Pfister DG, Heelan RT, Kris MG. Miller VA, et al. Am J Clin Oncol. 1995 Aug;18(4):303-6. doi: 10.1097/00000421-199508000-00007. Am J Clin Oncol. 1995. PMID: 7625371 Clinical Trial.

5

Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule.

Rigas JR, Francis PA, Miller VA, Tong WP, Roistacher N, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: miller va. Cancer Chemother Pharmacol. 1995;35(6):483-8. doi: 10.1007/BF00686832. Cancer Chemother Pharmacol. 1995. PMID: 7882456 Clinical Trial.

6

Modulation of all-trans retinoic acid pharmacokinetics by liarozole.

Miller VA, Rigas JR, Muindi JR, Tong WP, Venkatraman E, Kris MG, Warrell RP Jr. Miller VA, et al. Cancer Chemother Pharmacol. 1994;34(6):522-6. doi: 10.1007/BF00685665. Cancer Chemother Pharmacol. 1994. PMID: 7923564 Clinical Trial.

7

High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.

Pisters KM, Tyson LB, Tong W, Fleisher M, Miller VA, Grant SC, Pfister DG, Rigas JR, Densmore CL, Krol G, Heelan RT, Sirotnak FM, Bertino JR, Kris MG. Pisters KM, et al. Among authors: miller va. Clin Cancer Res. 1996 Nov;2(11):1819-24. Clin Cancer Res. 1996. PMID: 9816135 Clinical Trial.

8

Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.

Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, Gill GM, Loewen GR, Truglia JA, Ulm EH, Warrell RP Jr. Miller VA, et al. Clin Cancer Res. 1996 Mar;2(3):471-5. Clin Cancer Res. 1996. PMID: 9816192 Clinical Trial.

9

Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors.

Rigas JR, Kris MG, Miller VA, Pisters KM, Heelan RT, Grant SC, Fennelly DW, Chou TC, Sirotnak FM. Rigas JR, et al. Among authors: miller va. Ann Oncol. 1999 May;10(5):601-3. doi: 10.1023/a:1026404812699. Ann Oncol. 1999. PMID: 10416013 Free article. Clinical Trial.

10

Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.

Miller VA, Krug LM, Ng KK, Pizzo B, Perez W, Heelan RT, Kris MG. Miller VA, et al. J Clin Oncol. 2000 Mar;18(6):1346-50. doi: 10.1200/JCO.2000.18.6.1346. J Clin Oncol. 2000. PMID: 10715307 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters